Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
Drug Trafficking/Dealing
WSJ News Exclusive | DEA Pressed ADHD-Drug Makers About Impact of Telehealth Firms on Surging Demand
The Drug Enforcement Administration told makers of medication for attention-deficit hyperactivity disorder that it was concerned that “aggressive marketing practices”...
Marijuana Retail Licenses in New York Are Going First to Those Convicted of Drug Crimes
New York regulators want people who were affected by marijuana criminalization to get the first licenses to sell recreational pot...
WSJ News Exclusive | DEA Investigating ADHD Telehealth Provider Done
U.S. Drug Enforcement Administration agents have questioned people about telehealth company Done Global Inc.’s practices for prescribing controlled substances, according...
